Skip to content
★ Sign in to follow
GA

Glen A. Farmer

Immune Therapeutics, Inc.
Total declarations
1
Company
1
▲ Purchases (1 ops.)
€17k
▼ Sales (0 ops.)
—

Latest filing published 22 Feb 2023 for Immune Therapeutics, Inc., €17k.

Filing timeline

BuySale
Glen A. Farmer

Insider track record

Disclosed buys
1
Disclosed sells
0
Signal history

No signal scores available.

Closed purchases

Market purchases
1

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

Glen A. Farmer: trading record in brief

Glen A. Farmer has a single filing on record, published on 22 February 2023: an open-market purchase of €17k in Immune Therapeutics, Inc. One trade is not enough to describe a pattern. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.

Companies and markets linked to Glen A. Farmer

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations1 total
  • ▲
    Chief Financial OfficerExecutivesImmune Therapeutics, Inc.
    18,405 USD27SEC
    409,000 shares@ US$0.045100.0% of flowCommon StockSEC:0001493152-23-005800:0
    Canonical exit: 11 May 2023 (T+90)

1 of 1 declaration